Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. M. Semenov
Observed name:
A.M. Semenov
Institution:
SuperGen (United States)
Observed institution:
SuperGen (United States)
ORCID:
0000-0003-1247-4978
Observed ORCID:
0000-0003-1247-4978
OpenAlex ID:
A5126571016
Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry
2025
·
N.A. Shamalov
, M.Yu. Martynov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
5
Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry
2026
·
N.A. Shamalov
, M.Yu. Martynov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
4
Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry
2026
·
N.A. Shamalov
, M.Yu. Martynov
, et al.
·
S S Korsakov Journal of Neurology and Psychiatry
·
3
Predicting the safety of intravenous thrombolysis with Fortelyzin in patients over 60 years of age with ischemic stroke using the THRIVE scale
2026
·
N. A. Shamalov
, M. Yu. Martynov
, et al.
·
Neurology neuropsychiatry Psychosomatics
PDF
Show more works
View as search
Works count:
4
Citation count:
12
H-index:
3
I10-index:
Year
Topic
Type